Budesonide

Major

Budesonide Insulin Glargine, Recombinant Basaglar Reduced blood glucose lowering effect of insulin Details Budesonide Insulin Icodec-Abae Awiqli Reduced efficacy of insulin icodec-abae Details Budesonide Itraconazole Sporanox Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Ivacaftor Kalydeco Increased budesonide exposure Details Budesonide Ivosidenib Tibsovo Reduced exposure of sensitive CYP3A4 substrates and risk of loss of efficacy Details Budesonide Ketoconazole Extina Increased budesonide exposure Details Budesonide Ketoprofen Actron® Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Ketorolac Acular Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Larotrectinib Increased sensitive CYP3A4 substrate exposure and increase in the incidence or severity of adverse reactions Details Budesonide Lefamulin Xenleta Increased sensitive CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related toxicities associated wi... Details Budesonide Lenacapavir Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of Cushing's syndrome and adrenal suppression Details Budesonide Letermovir Prevymis Increased budesonide exposure Details Budesonide Levofloxacin Levaquin An increased risk of tendon rupture Details Budesonide Lomefloxacin An increased risk of tendon rupture Details Budesonide Lomitapide Increased budesonide exposure Details Budesonide Lonafarnib Zokinvy Increased budesonide exposure Details Budesonide Lornoxicam Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Loxoprofen Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Lumacaftor Reduced exposure to CYP3A substrate Details Budesonide Lumiracoxib Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Lutetium Lu 177 Dotatate Decreased lutetium Lu 177 dotatate efficacy Details Budesonide Macimorelin False-positive or false-negative adult growth hormone deficiency diagnosis Details Budesonide Maribavir Livtencity Increased budesonide exposure Details Budesonide Meclofenamate Meclodium® Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Mefenamic Acid Ponstel® Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Meloxicam Alloxate Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Mitapivat Aqvesme Reduced CYP3A substrate exposure Details Budesonide Morniflumate Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Moxifloxacin Avelox An increased risk of tendon rupture Details Budesonide Nabumetone Relafen Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Nadifloxacin An increased risk of tendon rupture Details Budesonide Nadroparin Increased risk of bleeding Details Budesonide Naproxen Aleve Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Nefazodone Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Nelfinavir Viracept Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Nepafenac Ilevro Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Netupitant Increased exposure of CYP3A4 substrate Details Budesonide Niflumic Acid Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Nilotinib Increased budesonide exposure Details Budesonide Nimesulide Increased risk of gastrointestinal ulcer or bleeding Details